Obexelimab Uses, Dosage, Side Effects and more
Obexelimab is under investigation in clinical trial NCT02725515 (A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus).
| Trade Name | Obexelimab |
| Generic | Obexelimab |
| Obexelimab Other Names | Obexelimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
